Exploring synaptic vesicles: Key players in neuronal communication.
Synaptic vesicles are essential membrane-bound organelles located in the axon terminals
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Synaptic vesicles are essential membrane-bound organelles located in the axon terminals
neuron and stored in vesicles until an action potential triggers their release into the synaptic cleft. Upon release, neurotransmitters bind to specific receptors on the postsynaptic neuron, leading to various…
role in the termination of neurotransmission by rapid reuptake of dopamine (DA) from the synaptic cleft into presynaptic terminals where it will be degraded by monoamino oxidase. With the blockade ... level of dopamine…
molecules in living cells. Here we present a model of electromagnetic forces in the synaptic cleft using the bidomain theory as a framework and the averaged field theory ... voltage cell membrane amplification due to…
membrane hyperpolarized, that may obstacle the release of synaptic vesicles content into the synaptic cleft. Moreover, AD rats gave the lowest significant (PÃ?¢Ã?Â?Ã?¤0.05) poking frequency compared
post-synaptic membranes, the synaptic cleft, and the surrounding glial cells and extracellular matrix all play a role in the correct connection between pre- and post-synaptic nerve cells. Synaptopathy
brain parenchyma and functional interactions with synaptic elements (axon terminals, dendritic spines, synaptic clefts, perisynaptic astrocytic processes) are regulated by neuronal activity and sensory experience…
transmission involves the release of neurotransmitters from the presynaptic neuron, their diffusion across the synaptic cleft, and their binding to receptors on the postsynaptic neuron, triggering a cascade of…
main excitatory neurotransmitter in the CNS. The concentration of glutamate in the synaptic cleft is tightly regulated by the interplay between glutamate release and glutamate clearance. Abnormal glutamate release…
influence of ligand binding to the receptor on free ligand concentration in the synaptic cleft is rarely considered, especially when the number of ligand molecules vastly exceeds the number ... case. This may provide an…
released by neurons at synapses, where they transmit signals across small gaps called synaptic clefts to other neurons, muscles or glands. These chemical messengers can be broadly classified into several
neurofibrillary tangles. Current allopathic treatments are focused on increasing the neurotransmitter Acetylcholine in synaptic clefts, but they are largely ineffective at improving disease prognosis. Holistic…
inhibitory motor nerve endings, blocks glycine and gamma amino butyric acid (GABA) across the synaptic cleft
acts by inhibiting reuptake of serotonin (5-HT), dopamine (DA), norepinephrine (NE) in the synaptic cleft, binding to the GABA-A and GABA-B receptors thereby inhibiting the binding
More than 4% of the human genome encodes cell receptors; these are
coupled neutral amino acid transporter (SNAT) 3, SNAT5, and mature SNAT2, suggesting excitotoxicity in synaptic cleft and shortage of Glu and Gln in astrocytes and neurons. Gln-supplementation
AChE inhibitors, which block the catabolism of acetylcholine and increase acetylcholine concentrations in the synaptic cleft. Drug repositioning or drug repurposing is one of the latest strategies
reward system by inducing release of dopamine and to some extent norepinephrine, in the synaptic clefts of the nucleus accumbens and other terminal areas. They offer not only a sense
serotonin (5-HT) signaling and developing molecules that enhance 5-HT concentration in the synaptic cleft have been debated as possible therapeutic strategies to slow the progression of Alzheimer
role in depression. Most antidepressant medications aim towards enhancement of serotonin concentration in synaptic clefts. However, only 50% of the patients receiving the treatment responds and in the responding patients
catecholamine transporters in the CNS and prevents reuptake of norepinephrine and dopamine from the synaptic cleft. Unlike the psycho-stimulants cocaine and amphetamine, MPD does not exhibit direct actions
tyrosine kinase (PTK) and release of the neurotransmitters like serotonin and nor-adrenaline into synaptic clefts. This signalling cascade is likely responsible for physiologic responses, induced by the detection
clinical manifestations of AD by delaying the breakdown of acetylcholine (ACh) released into synaptic clefts. Moreover, there is evidence that ACh modulates EEG alpha frequency. Objectives: the objectives of this
AChE inhibitors, which block the catabolism of acetylcholine and increase acetylcholine concentrations in the synaptic cleft. Drug repositioning or drug repurposing is one of the latest strategies
block the function of acetylcholinesterase and thus cause excessive acetylcholine to accumulate in the synaptic cleft. ACh hydrolysis by AChE causes termination of cholinergic neurotransmission therefore, compounds…
For authors and organisers
Find the right journal for your paper and submit your manuscript.